CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
基本信息
- 批准号:7961530
- 负责人:
- 金额:$ 213.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-14 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
This is the first revision of the application by the University of Florida (UF) for a CTSA. The University of Florida (UF) has a rich environment of distinguished colleges, state-of-the-art research facilities and statewide health education and health delivery systems. These resources position UF at the forefront of institutions to train the next generation of clinical and translational investigators and to help overcome two major obstacles in our nation's clinical research enterprise: the translation of basic science discoveries to early investigations in humans and the translation of clinical research into better medical practice and healthcare delivery. UF has made considerable investments dedicated exclusively to accomplish these missions. Furthermore, in direct response to the Clinical and Translational Science Award initiative, it committed substantial new research and training resources and undertook major restructuring of its traditional reporting, research and training operations to create a trans-institutional Clinical and Translational Science Institute (CTSI). The Institute will provide the new intellectual home for clinical and translational research and training at UF, integrating and synergizing the scientific and educational activities of 12 colleges, two academic and clinical campuses, two regional healthcare systems and the 67 counties ofthe State of Florida. Accordingly, this proposal sets forth the following goals to be accomplished in implementing the Institutional CTSA program: 1) Create an environment through which individuals from diverse disciplines can interact, resources, services and technologies can be identified and accessed and local and regional barriers to collaborative research can be overcome; 2) Train a workforce of clinical and basic science investigators, clinical trialists, laboratory technicians, study coordinators and other related personnel who are required to establish and support multi- and interdisciplinary clinical and translational research teams3 3) Enhance the quality and availability of cutting-edge technologies and novel research programs to accelerate the discovery, development and application of new diagnostic and therapeutic modalities; and 4) Create new opportunities for clinical scientists and the citizens of Florida to collaborate in advancing education and research into the causes, prevention, diagnosis, treatment and cure of human disease. RELEVANCE (See instructions): The proposal is relevant to the ability of UF to transform the manner by which it conducts multi- and interdisciplinary clinical and translational research and training and by which it engages the citizens across the State of Florida in community-based participatory research, education, health care and health care delivery.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
这是佛罗里达大学(UF)申请CTSA的第一次修订。佛罗里达大学(UF)拥有丰富的环境,包括杰出的学院,最先进的研究设施和全州范围的健康教育和健康服务系统。这些资源的位置UF在机构的最前沿,以培养下一代的临床和翻译研究人员,并帮助克服在我们国家的临床研究企业的两个主要障碍:基础科学发现的翻译,在人类的早期调查和临床研究转化为更好的医疗实践和医疗保健服务。用友已作出相当大的投资专门用于完成这些任务。此外,作为对临床和转化科学奖倡议的直接回应,它投入了大量新的研究和培训资源,并对其传统的报告,研究和培训业务进行了重大重组,以创建一个跨机构的临床和转化科学研究所(CTSI)。该研究所将提供临床和转化研究和培训在UF新的智力家园,整合和协同12所学院,两个学术和临床校区,两个区域医疗保健系统和67个县的科学和教育活动的佛罗里达。因此,本提案提出了在实施机构CTSA计划时要实现的以下目标:1)创造一个环境,通过该环境,来自不同学科的个人可以进行互动,资源,服务和技术可以被识别和访问,并可以克服当地和区域合作研究的障碍; 2)培训临床和基础科学研究人员、临床试验人员、实验室技术人员,研究协调员和其他相关人员,他们需要建立和支持多个和跨学科临床和转化研究团队3 3)提高尖端技术和新研究项目的质量和可用性,以加速新诊断和治疗方式的发现,开发和应用;和4)为临床科学家和佛罗里达公民创造新的机会,合作推进人类疾病病因、预防、诊断、治疗和治愈的教育和研究。相关性(参见说明):该提案是有关UF的能力,以改变它进行多和跨学科的临床和转化研究和培训的方式,并通过它从事整个佛罗里达州的公民在以社区为基础的参与式研究,教育,医疗保健和医疗保健服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Wallace Stacpoole其他文献
Peter Wallace Stacpoole的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Wallace Stacpoole', 18)}}的其他基金
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10471783 - 财政年份:2017
- 资助金额:
$ 213.33万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10216314 - 财政年份:2017
- 资助金额:
$ 213.33万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
9517985 - 财政年份:2017
- 资助金额:
$ 213.33万 - 项目类别:
Personalized dosing of dichloroacetate for the treatment of rare and common diseases
二氯乙酸治疗罕见病和常见病的个性化剂量
- 批准号:
10010536 - 财政年份:2017
- 资助金额:
$ 213.33万 - 项目类别:
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)
DCA 治疗 PDC 缺陷的 3 期试验 IND 028,625 (02/04/2015)
- 批准号:
10436136 - 财政年份:2016
- 资助金额:
$ 213.33万 - 项目类别:
Phase 3 Trial of DCA in PDC Deficiency IND 028,625 (02/04/2015)
DCA 治疗 PDC 缺陷的 3 期试验 IND 028,625 (02/04/2015)
- 批准号:
9625517 - 财政年份:2016
- 资助金额:
$ 213.33万 - 项目类别:
Planning Grant for Phase 3 Trial of Dichloroacetate in PDH Deficiency
二氯乙酸治疗 PDH 缺乏症第三阶段试验的规划拨款
- 批准号:
7976507 - 财政年份:2010
- 资助金额:
$ 213.33万 - 项目类别:
Pharmacotoxicology of Trichloroethylene Metabolites
三氯乙烯代谢物的药理学
- 批准号:
7812724 - 财政年份:2009
- 资助金额:
$ 213.33万 - 项目类别:
相似海外基金
UCLA Pediatric Research Education Program in Bioinformatics, Computational Biology, and Omics
加州大学洛杉矶分校生物信息学、计算生物学和组学儿科研究教育项目
- 批准号:
10629061 - 财政年份:2023
- 资助金额:
$ 213.33万 - 项目类别:
Race, Ethnicity, Indigenous identity and Language preference for Pediatric research in the hospital setting (REIaL-P)
医院环境中儿科研究的种族、民族、土著身份和语言偏好 (REIaL-P)
- 批准号:
494504 - 财政年份:2023
- 资助金额:
$ 213.33万 - 项目类别:
Operating Grants
Application of Gabriella Miller Kids First Pediatric Research Data to a Predictive Model of Neuroblastoma
Gabriella Miller Kids First 儿科研究数据在神经母细胞瘤预测模型中的应用
- 批准号:
10757183 - 财政年份:2022
- 资助金额:
$ 213.33万 - 项目类别:
Pediatric Research Optimizing Methods in Stakeholder Engagement (PROMISE)
儿科研究优化利益相关者参与的方法(PROMISE)
- 批准号:
10580764 - 财政年份:2022
- 资助金额:
$ 213.33万 - 项目类别:
2022 Pediatric Research in Sports Medicine (PRiSM) Annual Conference
2022年运动医学儿科研究(PRiSM)年会
- 批准号:
10384604 - 财政年份:2021
- 资助金额:
$ 213.33万 - 项目类别:
Application of Gabriella Miller Kids First Pediatric Research Data to a Predictive Model of Neuroblastoma
Gabriella Miller Kids First 儿科研究数据在神经母细胞瘤预测模型中的应用
- 批准号:
10193881 - 财政年份:2021
- 资助金额:
$ 213.33万 - 项目类别:
2022 Pediatric Research in Sports Medicine (PRiSM) Annual Conference
2022年运动医学儿科研究(PRiSM)年会
- 批准号:
10540776 - 财政年份:2021
- 资助金额:
$ 213.33万 - 项目类别:
Clinical Pediatric Research Training for the Fetal-Neonatal Brain
胎儿-新生儿大脑的临床儿科研究培训
- 批准号:
10393548 - 财政年份:2020
- 资助金额:
$ 213.33万 - 项目类别:
Clinical Pediatric Research Training for the Fetal-Neonatal Brain
胎儿-新生儿大脑的临床儿科研究培训
- 批准号:
10646166 - 财政年份:2020
- 资助金额:
$ 213.33万 - 项目类别:
PediAtric ReseArch of Drugs, Immunoparalysis and Genetics during MODS (PARADIGM)
MODS 期间的药物、免疫麻痹和遗传学儿科研究 (PARADIGM)
- 批准号:
10640818 - 财政年份:2019
- 资助金额:
$ 213.33万 - 项目类别: